Randomized controlled trial2016Industry funded

Funded in part by General Mills

Plasma alkylresorcinols, biomarkers of whole-grain intake, are not associated with progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease

McKeown NM, Hruby A, Landberg R, Herrington DM, Lichtenstein AH

Public health nutrition · 7 citations

Review labels

Industry funded

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design
Randomized controlled trial (indexed by PubMed)
Studied in
People
Main outcome
Health markers and function
Intake measured by
Food frequency questionnaire

Who paid for it

Funding
Industry funded
Company
General Mills
University or hospital
Tufts Medical Center
Government
National Heart, Lung, and Blood Institute
Government
NHLBI NIH HHS
Grants
National Heart, Lung, and Blood Institute (U01 HL 45488)

Based on 4 listed funder(s).

Publication

Published
2015-04-23 · Public Health Nutr · vol. 19 · issue 2 · pp. 326–331
Publisher
Cambridge University Press
Cited
10 citations · more than 78% of similar papers · 1.2× the field average
References
39 works
Access
Free to read
Research areas
Food composition and properties · Bariatric Surgery and Outcomes · Phytoestrogen effects and research
Keywords
Medicine, Coronary artery disease, Internal medicine, Cardiology, Coronary atherosclerosis, Prospective cohort study, Artery, Endocrinology
MeSH
coronary vessels, humans, disease progression, resorcinols, diet, diet surveys, feeding behavior, postmenopause, aged, middle aged, female, atherosclerosis, coronary artery disease, biomarkers, secale, whole grains

5 authors

From US, SE

  • Nicola Mary McKeown · correspondingTufts University; Jean Mayer Human Nutrition Research Center on Aging
  • Adela HrubyMassachusetts Department of Public Health; Harvard University
  • Rikard LandbergKarolinska Institutet; Swedish University of Agricultural Sciences
  • David M. HerringtonAtrium Health Wake Forest Baptist
  • Alice Hinda LichtensteinTufts University; Jean Mayer Human Nutrition Research Center on Aging

Abstract

Objective

The objective of the present study was to examine the relationship between plasma alkyresorcinol (AR) concentrations, which are biomarkers of whole-grain intake, and atherosclerotic progression over 3 years in postmenopausal women with coronary artery disease.

Design

Plasma AR concentrations were measured by a validated GC-MS method in fasting plasma samples. Atherosclerosis progression was assessed using change in mean minimal coronary artery diameter (MCAD) and percentage diameter stenosis (%ST), based on mean proximal vessel diameter across up to ten coronary segments. Dietary intake was estimated using a 126-item interviewer-administered FFQ.

Setting

A prospective study of postmenopausal women participating in the Estrogen Replacement and Atherosclerosis trial.

Subjects

For the analysis of plasma AR concentrations and atherosclerotic progression, plasma samples and follow-up data on angiography were available for 182 women.

Results

Mean whole-grain intake was 9·6 (se 0·6) servings per week. After multivariate adjustment, no significant associations were observed between plasma AR concentrations and change in mean MCAD or progression of %ST. Plasma AR concentrations were significantly correlated with dietary whole grains (r=0·35, P<0·001), cereal fibre (r=0·33, P<0·001), bran (r=0·15, P=0·05), total fibre (r=0·22, P=0·003) and legume fibre (r=0·15, P=0·04), but not refined grains, fruit fibre or vegetable fibre.

Conclusions

Plasma AR concentrations were not significantly associated with coronary artery progression over a 3-year period in postmenopausal women with coronary artery disease. A moderate association was observed between plasma AR concentrations and dietary whole grains and cereal fibre, suggesting it may be a useful biomarker in observational studies.

Abstract via Europe PMC. Copyright remains with the authors or publisher.

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.